Literature DB >> 4109064

Pure-strain and genetically mosaic liver tumors histochemically identified with the -glucuronidase marker in allophenic mice.

H Condamine, R P Custer, B Mintz.   

Abstract

A histochemical procedure for beta-glucuronidase has been used to make visible the cellular genotypes of liver tumors and of surrounding normal liver clones in allophenic mice. The animals had lifelong genetic mosaicism for cells with the allele for low beta-glucuronidase activity (g/g genotype, C3H strain) and cells with the allele for high activity (G/G genotype, C57BL/6 or BALB/c strain). The former strain is also hepatoma-susceptible; both the latter are nonsusceptible. Of 12 "spontaneous" hepatomas examined, nine were entirely of susceptible-strain hepatic cells and one was of the nonsusceptible strain; the pure-strain tumors usually arose in a liver environment containing clones of each genotype. The cells therefore behave largely autonomously with respect to gene control of tumor susceptibility. However, two tumors with malignant cells of both genotypes were formed, which suggests some measure of intercellular transmission of tumor information. Alternatively, transformation might have occurred in two or more cells concurrently. Mosaic tumors in either case imply that even a hepatoma of one inbred strain, whether in a single-genotype animal or an allophenic mouse, may comprise diverse clones of transformed cells. Possibly many or all hepatomas may therefore be genetically complex entities.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4109064      PMCID: PMC389345          DOI: 10.1073/pnas.68.9.2032

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  The effect of mutation on the intracellular location of beta-glucuronidase.

Authors:  K PAIGEN
Journal:  Exp Cell Res       Date:  1961-11       Impact factor: 3.905

2.  Isozymes and genetic control of NADP-malate dehydrogenase in mice.

Authors:  N S Henderson
Journal:  Arch Biochem Biophys       Date:  1966-10       Impact factor: 4.013

3.  Components of the major urinary protein complex in inbred mice: separation and peptide mapping.

Authors:  J S Finlayson; J F Mushinski; D M Hudson; M Potter
Journal:  Biochem Genet       Date:  1968-09       Impact factor: 1.890

4.  Histochemical demonstration of beta-glucuronidase activity during sequential molar development in the Swiss albino mouse.

Authors:  A F Badran; E P Leonard; D V Provenza
Journal:  Histochemie       Date:  1970

5.  Gene control of mammalian pigmentary differentiation. I. Clonal origin of melanocytes.

Authors:  B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1967-07       Impact factor: 11.205

6.  Isoenzymes of phosphoglucose isomerase in mice.

Authors:  N D Carter; C W Parr
Journal:  Nature       Date:  1967-11-04       Impact factor: 49.962

7.  THE CYTOLOGIC DEMONSTRATION OF BETA-GLUCURONIDASE EMPLOYING NAPHTHOL AS-BI GLUCURONIDE AND HEXAZONIUM PARAROSANILIN; A PRELIMINARY REPORT.

Authors:  M HAYASHI; Y NAKAJIMA; W H FISHMAN
Journal:  J Histochem Cytochem       Date:  1964-04       Impact factor: 2.479

8.  Major urinary protein complex of normal mice: origin.

Authors:  J S Finlayson; R Asofsky; M Potter; C C Runner
Journal:  Science       Date:  1965-08-27       Impact factor: 47.728

9.  "Intrinsic" immunological tolerance in allophenic mice.

Authors:  B Mintz; W K Silvers
Journal:  Science       Date:  1967-12-15       Impact factor: 47.728

10.  Cytochemistry and electron microscopy. The preservation of cellular ultrastructure and enzymatic activity by aldehyde fixation.

Authors:  D D SABATINI; K BENSCH; R J BARRNETT
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

View more
  12 in total

1.  Mosaic pattern of ornithine transcarbamylase expression in spfash mouse liver.

Authors:  N Shiojiri; H Imai; S Goto; T Ohta; K Ogawa; M Mori
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Biochemical and genetic factors in the heat inactivation of murine beta-glucuronidase.

Authors:  K Herrup; R J Mullen
Journal:  Biochem Genet       Date:  1977-08       Impact factor: 1.890

3.  Studies of X-chromosome inactivation with an improved histochemical technique for ornithine carbamoyltransferase.

Authors:  K A Wareham; S Howell; D Williams; E D Williams
Journal:  Histochem J       Date:  1983-04

4.  Phylogenetic analysis of developmental and postnatal mouse cell lineages.

Authors:  Stephen J Salipante; Arnold Kas; Eva McMonagle; Marshall S Horwitz
Journal:  Evol Dev       Date:  2010 Jan-Feb       Impact factor: 1.930

5.  A potent modifier of liver cancer risk on distal mouse chromosome 1: linkage analysis and characterization of congenic lines.

Authors:  Andrea Bilger; L Michelle Bennett; Reynaldo A Carabeo; Teresa A Chiaverotti; Cecily Dvorak; Kristin M Liss; Susan A Schadewald; Henry C Pitot; Norman R Drinkwater
Journal:  Genetics       Date:  2004-06       Impact factor: 4.562

6.  Mosaic mice with teratocarcinoma-derived mutant cells deficient in hypoxanthine phosphoribosyltransferase.

Authors:  M J Dewey; D W Martin; G R Martin; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Normal genetically mosaic mice produced from malignant teratocarcinoma cells.

Authors:  B Mintz; K Illmensee
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

8.  Clonal origin of mouse liver cell tumors.

Authors:  S Howell; K A Wareham; E D Williams
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

9.  Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains.

Authors:  Robert R Maronpot
Journal:  J Toxicol Pathol       Date:  2009-04-06       Impact factor: 1.628

10.  Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17.

Authors:  Stephanie E-M Peychal; Andrea Bilger; Henry C Pitot; Norman R Drinkwater
Journal:  Carcinogenesis       Date:  2009-03-02       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.